For the year ending 2025-12-31, CRBU has $175,367K in assets. $53,192K in debts. $12,360K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 12,360 | |||
| Marketable securities, short-term | 126,980 | |||
| Accounts receivable | 69 | |||
| Contract assets | 1,006 | |||
| Other receivables | 1,904 | |||
| Prepaid expenses and other current assets | 2,913 | |||
| Total current assets | 145,232 | |||
| Equity method investments | 0 | |||
| Marketable securities, long-term | 3,505 | |||
| Property and equipment, net | 6,760 | |||
| Operating lease, right of use assets | 17,670 | |||
| Other assets | 2,200 | |||
| Total assets | 175,367 | |||
| Accounts payable | 5,783 | |||
| Accrued expenses and other current liabilities | 16,535 | |||
| Operating lease liabilities, current | 1,201 | |||
| Deferred revenue (0 and 2,487 from related party as of december31, 2025, and december31, 2024, respectively) | 1,895 | |||
| Total current liabilities | 25,414 | |||
| Deferred revenue, net of current portion (0 and 1,243 from related party as of december31, 2025, and december31, 2024, respectively) | 1,752 | |||
| Mskcc success payments liability | 0 | |||
| Operating lease liabilities, non-current | 26,026 | |||
| Deferred tax liabilities | 0 | |||
| Total liabilities | 53,192 | |||
| Common stock, par value 0.0001 per share, 300,000,000 shares authorized at december31, 2025, and december31, 2024 95,143,690 and 92,378,577 shares issued and outstanding at december31, 2025, and december31, 2024, respectively | 9 | |||
| Additional paid-in-capital | 718,578 | |||
| Accumulated other comprehensive income | 103 | |||
| Accumulated deficit | -596,515 | |||
| Total stockholders equity | 122,175 | |||
| Total liabilities and stockholders equity | 175,367 | |||
Caribou Biosciences, Inc. (CRBU)
Caribou Biosciences, Inc. (CRBU)